HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ceramide monohexoside

Also Known As:

monohexosylceramide

Networked: 19 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Fujiwaki, Takehisa: 3 articles (06/2004 - 04/2002)
2.	Taketomi, Tamotsu: 3 articles (06/2004 - 04/2002)
3.	Yamaguchi, Seiji: 3 articles (06/2004 - 04/2002)
4.	Tasaka, Masaru: 2 articles (06/2004 - 08/2002)
5.	Albi, Elisabetta: 1 article (01/2020)
6.	Alessenko, Alice V: 1 article (01/2020)
7.	Calado, Ângelo: 1 article (01/2020)
8.	Conceição, Vasco A: 1 article (01/2020)
9.	Cruz-Machado, Ana Rita: 1 article (01/2020)
10.	Fonseca, João Eurico: 1 article (01/2020)

Related Diseases

1.	Neoplasms (Cancer) 12/01/1976 - "A study on ceramide monohexoside from AH 109A, a strain of ascitic tumor cell in Donryu rats." 02/01/1994 - "Galactosylceramide (GalCer) was the major ceramide monohexoside (CMH), and glucosylcerebroside never comprised more than 6% of this fraction in any tumor type. "
2.	Gaucher Disease (Gaucher's Disease) 08/25/2002 - "It was indicated that the accumulation of ceramide monohexoside in such samples from Gaucher disease patients can be easily detected with this DE-MALDI-TOF-MS method." 06/25/2004 - "The mass spectrum of the Gaucher disease patient showed additional ions with m/z values corresponding to different ceramide monohexoside (CMH) species. " 02/13/2015 - "Gaucher disease (GD) is a rare genetic disorder that arises from lipid species, especially monohexosylceramide (MHC), accumulating in different organs. " 08/25/2002 - "After mild alkaline treatment of the crude lipids, a sphingolipid fraction was prepared and analyzed by DE-MALDI-TOF-MS. The results were as follows: (a) in all the specimens, peaks of ceramide monohexoside and sphingomyelin were detected in both the controls and Gaucher disease patients; (b) in pericardial fluid, peritoneal fluid, and serum, the ceramide monohexoside/sphingomyelin ratio was increased in the Gaucher disease patients compared with in the controls. "
3.	Parkinson Disease (Parkinson's Disease) 01/01/2020 - "Numerous experiments have highlighted the involvement of ceramide and monohexosylceramide metabolism in the pathophysiology of the sporadic forms of Parkinson's disease. " 01/01/2013 - "Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylceramide (a monohexosylceramide) into glucose and ceramide, is the most common genetic risk factor for sporadic Parkinson's disease (PD). "
4.	Cognitive Dysfunction 01/01/2013 - "Among PD patients, levels of ceramide C16:0, C18:0, C20:0, C22:0, and C24:1 and monohexosylceramide C16:0, C20:0 and C24:0 species were higher (all P<0.05) in those with versus without cognitive impairment. " 01/01/2013 - "Plasma ceramide, monohexosylceramide, and lactosylceramide levels in 26 cognitively normal PD patients, 26 PD patients with cognitive impairment or dementia, and 5 cognitively normal non-PD controls were determined by LC/ESI/MS/MS. Levels of all lipid species were higher in PD patients versus controls. "
5.	Inborn Genetic Diseases (Disease, Hereditary) 02/13/2015 - "Gaucher disease (GD) is a rare genetic disorder that arises from lipid species, especially monohexosylceramide (MHC), accumulating in different organs. "

Related Drugs and Biologics

1.	Ceramides
2.	Lipids
3.	Glycolipids
4.	Glucose (Dextrose)
5.	ceramide dihexoside
6.	Silica Gel
7.	Glycerophospholipids (Phosphoglycerides)
8.	Acidic Glycosphingolipids
9.	Neutral Glycosphingolipids
10.	Triglycerides (Triacylglycerol)